Home / Recalls / Med Shop Total Care Inc. / D-0708-2021

D-0708-2021 Class I Terminated

Recalled by Med Shop Total Care Inc. — Longview, TX

FDA drug recall D-0708-2021 was initiated by Med Shop Total Care Inc. on Oct 5, 2020 and is designated Class I. Reason for recall: Non-Sterility The recall status is terminated (terminated Aug 17, 2023). Affected quantity: 126 mL.

Recall Details

Product Type: Drugs
Report Date: Aug 18, 2021
Initiation Date: Oct 5, 2020
Termination Date: Aug 17, 2023
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 126 mL

Product Description

HYDROMORPHONE HCL-BUPIVACAINE HCL-BACLOFEN PF INJECTABLE 21 mL syringes in various strengths: a) 2.5MG-1.25MG-0.5MCG/ML, b) 10MG-5MG-10MCG/ML, c) 2MG-1MG-10MCG/ML, d) 10MG-5MG-10MCG/ML, e) 15MG-5MG-2000MCG/ML, f) 8MG-10MG-400MCG/ML, Rx only, Med Shop Total Care 470 East Loop 281 Longview, TX 75605

Reason for Recall

Non-Sterility

Distribution Pattern

Texas and Puerto Rico

Code Information

Lot #: a)10012020@42, b) 10012020@43, c) 10012020@44, d) 10012020@46, e) 09302020@16, f) 09302020@44, BUD 10/29/2020

Source

Dataset: openFDA drug recall enforcement reports
FDA record: This recall in openFDA (JSON)
Enforcement Report: Search FDA's Enforcement Report for D-0708-2021
openFDA file date: Nov 3, 2026
Loaded by RegDataLab: Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Other recalls by Med Shop Total Care Inc.

D-0709-2021 Class I — HYDROMORPHONE HCL-BUPIVACAINE HCL-CLONIDINE HCL PF INJECTABLE 21 mL syringes in… (Oct 5, 2020)
D-0715-2021 Class I — MORPHINE-BUPIVACAINE-FENTANYL PF 30MG-15MG-2000MCG/ML INJECTABLE 21 mL syringe… (Oct 5, 2020)
D-0711-2021 Class I — HYDROMORPHONE HCL-BUPIVACAINE HCL-FENTANYL PF INJECTABLE 21 mL syringe in… (Oct 5, 2020)
D-0704-2021 Class I — BUPIVACAINE HCL-BACLOFEN PF INJECTABLE 40MG-4000MCG/ML, 21 mL syringe, Rx only… (Oct 5, 2020)
D-0717-2021 Class I — HYDROMORPHONE HCL-BUPIVACAINE HCL PF INJECTABLE 21 and 22 mL syringes in various… (Oct 5, 2020)
D-0713-2021 Class I — MORPHINE-BUPIVACAINE-KETAMINE PF INJECTABLE 21 mL syringe in two strengths: a)… (Oct 5, 2020)
D-0710-2021 Class I — MORPHINE-BUPIVACAINE PF INJECTABLE 21 mL, 22 mL, 23 mL, 41 mL and 43 mL syringes… (Oct 5, 2020)
D-0716-2021 Class I — HYDROMORPHONE HCL-BUPIVACAINE HCL-SUFENTANIL PF 25MG-9MG-110MCG/ML INJECTABLE 21… (Oct 5, 2020)
D-0707-2021 Class I — FENTANYL-BUPIVACAINE HCL-BACLOFEN PF INJECTABLE 575MCG-18MG-6000MCG/ML, 21 mL… (Oct 5, 2020)
D-0705-2021 Class I — BUPIVACAINE HCL-LIORESAL PF INJECTABLE 7.5MG-1625MCG/ML, 41 mL syringe, Rx only… (Oct 5, 2020)